$12.59
-0.1-0.79%
At close: May 8, 5:00 PM EST
$12.59
N/A
After Hours: May 8, 4:00 PM EST
Medifast Inc Stock Guidance
MEDNYSE
Earnings: Q1 2026 Earnings were released on Mon May 4th, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 6 days agoClick to view the webcast
Medifast (MED) last issued guidance on May 4, 2026 for fiscal year 2026. The company guided earnings per share in the range of $-2.75 - $-1.55, compared to a consensus EPS estimate of $-1.98. Medifast also guided revenue in the range of $270.00M - $300.00M for the period.
Compared to prior guidance, Medifast maintained its EPS outlook from a previous range of $-2.75 - $-1.55. On the revenue side, the company maintained its revenue forecast from a prior range of $270.00M - $300.00M.
Medifast has issued 18 guidance updates between August 3, 2022 and May 4, 2026. During this period, the company raised its outlook 2 times and lowered it 12 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 4, 2026
Guidance Period
Full Year 2026
EPS Guidance Range
$-2.75 - $-1.55
Revenue Guidance Range
$270.00M - $300.00M
Medifast Guidance History
Review all historical guidance issued by Medifast, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Medifast (MED)?
The most recent guidance for Medifast (MED) was reported on May 4, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $-2.75 to $-1.55, compared to the estimated EPS of $-1.98. Additionally, Medifast forecasted revenue between $270.00M and $300.00M for the period.
What EPS range did Medifast (MED) guide for?
Medifast (MED) guided EPS in the range of $-2.75 to $-1.55 for the fiscal year 2026. The consensus analyst EPS estimate is $-1.98.
What revenue range did Medifast (MED) guide for?
Medifast (MED) guided revenue in the range of $270.00M to $300.00M for the fiscal year 2026.
Did Medifast (MED) raise or lower guidance?
Medifast (MED) maintained its EPS guidance from a prior range of $-2.75 - $-1.55 to $-2.75 - $-1.55 for the fiscal year 2026.
When did Medifast (MED) last issue guidance?
Medifast (MED) last issued guidance on May 4, 2026 for the fiscal year 2026.
